Wire
NRX Pharmaceuticals' Hope Therapeutics, Zeta Surgical Treat First Patient With Zeta TMS Navigation System
NRX Pharmaceuticals' (NRXP) Hope Therapeutics unit and Zeta Surgical said Tuesday that the first patient was treated with the US Food and Drug Administration-cleared Zeta TMS Navigation System at a Hope clinic in Sarasota.Transcranial magnetic stimulation, or TMS, is a non-invasive treatment mainly used for treatment-resistant depression, and is also used in other neuropsychiatric conditions such as obsessive-compulsive disorder, according to a statement.The system is now being integrated into outpatient treatment workflows at Hope clinics for eligible patients, including those with major depressive disorder, per the statement.Price: $3.81, Change: $-0.09, Percent Change: -2.31%
$NRXP
